GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tristel PLC (FRA:R1V) » Definitions » ROE % Adjusted to Book Value

Tristel (FRA:R1V) ROE % Adjusted to Book Value : 2.76% (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Tristel ROE % Adjusted to Book Value?

Tristel's ROE % for the quarter that ended in Dec. 2024 was 17.28%. Tristel's PB Ratio for the quarter that ended in Dec. 2024 was 6.26. Tristel's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 2.76%.


Tristel ROE % Adjusted to Book Value Historical Data

The historical data trend for Tristel's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tristel ROE % Adjusted to Book Value Chart

Tristel Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.32 0.62 2.84 3.24

Tristel Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.65 3.88 2.92 3.39 2.76

Competitive Comparison of Tristel's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Tristel's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tristel's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tristel's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Tristel's ROE % Adjusted to Book Value falls into.



Tristel ROE % Adjusted to Book Value Calculation

Tristel's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=20.71% / 6.39
=3.24%

Tristel's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=17.28% / 6.26
=2.76%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tristel ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Tristel's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Tristel Business Description

Traded in Other Exchanges
Address
Fordham Road, Unit 1B, Lynx Business Park, Newmarket, Snailwell, Cambridgeshire, GBR, CB8 7NY
Tristel PLC is a player in the healthcare platform. The company is a manufacturer of chlorine dioxide chemistry used for the decontamination of medical devices. Its operating segments include three sectors, Hospital medical device decontamination products which are used predominantly for infection control in hospitals; manufacture and sale of hospital environmental surface disinfection products; and pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare. The company generates the majority of its revenue from Hospital medical device decontamination.

Tristel Headlines

No Headlines